Clinical Trial Update: A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS

View source ↗

Summary

Post-market study to evaluate long-term effectiveness and safety of NTX100 in Restless Legs Syndrome; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• NTX100

Snippet

Sponsor: Noctrix Health, Inc. | Conditions: Restless Legs Syndrome | Status: ACTIVE_NOT_RECRUITING